NCT00772681View on ClinicalTrials.gov

Efficacy of Chemoradiotherapy After Neoadjuvant Cisplatin and Docetaxel in the Nasopharynx Carcinoma

PHASE4CompletedINTERVENTIONAL

Enrollment

57

Participants

Timeline

Start Date

October 31, 2004

Primary Completion Date

March 31, 2008

Study Completion Date

March 31, 2008

Conditions

Head and Neck Neoplasms

Interventions

DRUG

docetaxel and cisplatin

3 cycles of docetaxel 75mg/m2 and 100mg/m2 cisplatin combination every 3 weeks

Trial Locations (1)

Unknown

Sanofi-Aventis Administrative Office, Istanbul

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Sanofi

INDUSTRY